Sponsor Pipeline

Taisho Pharmaceutical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
5
Recruiting
4
Phase 3
Active Trials by Phase
Phase 3
4
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07285304 A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis Hyperphosphatemia Patients on Hemodialysis Recruiting
NCT07285291 A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate… Hyperphosphatemia Patients on Hemodialysis Recruiting
NCT07548840 A Clinical Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis Hyperphosphatemia Patients on Hemodialysis Recruiting
NCT07548853 A Clinical Study of TS-172 in Hyperphosphatemia Patients on Peritoneal Dialysis Hyperphosphatemia Patients on Peritoneal Dialysis Recruiting
Phase 1
NCT07231029 A Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment Patients With Mild or Moderate Hepatic Impairment Recruiting
Get alerts when Taisho Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free